CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights ...

Good morning. Welcome to the Sage Therapeutics' Fourth Quarter and Full-Year 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast ...

One of the memories I have from covering the state finals in softball is a conversation I had with an area coach. It happened while we were watching Lemont pitcher Sage Mardjetko mow down batter after ...

Two days after she pitched Lemont to the Class 3A state championship, Sage Mardjetko was back to work at the school’s softball field. Only this time it wasn’t for her own benefit. Lemont coach ...

Annual survey finds 93% of finance leaders under pressure to accelerate their close process; sees a 50% year-over-year increase in the number of organizations using cloud-based or hybrid accounting ...

DALLAS, June 08, 2022 (GLOBE NEWSWIRE) -- Sage (FTSE: SGE), the leader in accounting, financial, HR, and payroll technology for small and mid-sized businesses (SMBs) today kicked off Sage Partner ...

SAGE-421: an oral, NMDA receptor PAM that Sage plans to study for potential use in neurodevelopmental disorders and cognitive recovery and rehabilitation. FINANCIAL RESULTS FOR THE SECOND QUARTER 2022 ...

Barry Greene: So we — in the scientific exchange that we have with potential prescribers and our investigators, we’re hearing different views. And the good news is that we have data with Zuranolone as ...

Sage Therapeutics, Inc., a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the fourth quarter and ...